Video

Michael Thase, MD: How Managing Side Effects Improves Treatment Adherence

Author(s):

Patients ask about side effects a lot, but physicians aren't always keen to listen, according to Michael Thase, MD. Here's why they should.

Michael Thase, MD:

The final portion of my talk is about managing side effects. Our patients tell us that we don't ask enough about their side effects and we don't do enough about their side effects.

A patient who perceives a medicine to be, to have too much baggage, too many side effects, and a doctor who doesn't seem interested, is a patient who's very likely to drop out of treatment. Each time people drop out of treatment, their chances of recovering diminish and the chances of becoming chronically ill - ill over years - increases.

So I would say be attuned to your patients' side effect complaints and do what you can do to manage them. This might mean changing drugs, using reduced doses, and on occasion using certain antidotes.

Related Videos
Davide Matino, MD, MSc: Bringing Marstacimab Treatment to Hemophilia A and B
Ben Samelson-Jones,Ben Samelson-Jones, MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy
Françoise Bernaudin, MD: A Decade of Follow-up Reveals allo-SCT Superiority Over SOC for Sickle Cell Anemia
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Jörn Schattenberg, MD | Credit: Novo Nordisk
Jörn Schattenberg, MD | Credit: Novo Nordisk
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
© 2024 MJH Life Sciences

All rights reserved.